NCT02955186View on ClinicalTrials.gov

Saracatinib and Alcohol Drinking

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 9, 2017

Primary Completion Date

April 24, 2019

Study Completion Date

June 7, 2019

Conditions
Alcohol Drinking
Interventions
DRUG

Saracatinib

Saracatinib 125 mg once per day for 8 days

DRUG

Placebos

Placebo once per day for 8 days

Trial Locations (1)

06519

CMHC, Substance Abuse Center, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT02955186 - Saracatinib and Alcohol Drinking | Biotech Hunter | Biotech Hunter